InnoCan Pharma Corporation announced that it has entered into a non-brokered private placement of 9,679,000 units at a price of CAD 0.85 per unit for gross proceeds of CAD 8,227,150 on October 8, 2021. Each unit consists of one share and one share purchase warrant. Each warrant entitles the holder thereof to purchase one additional common share of the company at an exercise price of CAD 1.10 per share for a period of five years from closing of the transaction. The transaction is expected to close on or about October 13, 2021.